PDS Biotechnology (PDSB) Misses Q1 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.32), $0.10 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance